Helixmith Co (084990.KQ) Stock Price

Helixmith Co Price

KOSDAQ·CLOSED
4,565.00
​
Market closed

Revenue at Helixmith Co has contracted by 2.1% per year over the past 19 years to 2.60 B KRW. Earnings per share have grown at 2.2% per year over the last 6 years. For Helixmith Co, the net margin of -16.7% is up versus -2,199.2% a few years ago.

Helixmith Co stock price

Access this data via the Eulerpool API

Helixmith Co business model & stock analysis

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-29. The firm operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Frequently asked questions about Helixmith Co

5 analysts currently rate the Helixmith Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Helixmith Co share trades at 3.04 EUR (4,565.00 KRW).

The Helixmith Co share (084990.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (084990.KQ).

The revenue cannot currently be calculated for Helixmith Co.

The profit cannot currently be calculated for Helixmith Co.

The P/E ratio cannot be calculated for Helixmith Co at the moment.

The P/S cannot be calculated for Helixmith Co currently.

The Eulerpool Quality Score for Helixmith Co is 2/10.

The ISIN of Helixmith Co is KR7084990001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Helixmith Co is 084990.KQ. The ticker symbol is used to trade Helixmith Co shares on the stock exchange.

Fair ValueTerminal
4,428.05 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 29, 2005
ISIN
KR7084990001
Cusip
Y3127Y100
Market capitalization
214.51 B KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
1.51
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-0.31 %
Last updated Oct 9, 2026, 8:50 AM

Helixmith Co Peer Group

Helixmith Co Ticker

KOSDAQ · 084990.KQ

Helixmith Co FIGI

084990:KS · BBG000BJSK19084990:KQ · BBG000BJSKP3